InventaBioTech Inc. (OTCPK:INVB) announced that it has entered into a securities purchase agreement for a private placement of a unsecured senior convertible promissory note in the aggregate principal amount of $222,222 for gross proceeds of $200,000 with accredited investor FirstFire Global Opportunities Fund LLC, a fund managed by FirstFire Capital Management LLC on November 8, 2018. The note will carry a fixed coupon of 8% and would mature on November 8, 2019. The note is convertible into common shares, at a conversion price for each share equal to $0.25 till six months of issuance or more than six months after the issuance date, the lower of $0.25 or 65% multiplied by the lowest traded price of the shares during the 20 trading day period ending on the day before a notice of conversion is received by the company. The note may be prepaid, only in full, until the earlier of the first conversion date or 180 days from the issuance date. The company will also issue 555,555 warrants to issue common shares of the company. The warrant may be exercised at any time on or after November 8, 2018, and on or prior to the close of business on the 4 year anniversary of the Initial exercise date. The exercise price per share under the warrant shall be $0.40 per share, subject to adjustment. The company will issue the securities pursuant to exemption provided under Regulation D.